Literature DB >> 18041765

Developmental expression and differential cellular localization of obscurin and obscurin-associated kinase in cardiac muscle cells.

Andrei B Borisov1, Maide O Raeker, Mark W Russell.   

Abstract

Obscurin and obscurin-associated kinase are two products of the obscurin transcriptional unit that encodes a recently identified giant muscle-specific protein obscurin. In this study, we characterized the developmental expression and cellular localization of obscurin and obscurin-associated kinase in cardiac muscle cells. We cloned murine obscurin-associated kinase and found that it is abundantly expressed in the heart as two isotypes encoded by 2.2 and 4.9 kb sequences. The 2.2 kb isotype of the kinase was more prominently expressed than the 4.9 kb isotype. Both obscurin and the kinase-like domains were progressively upregulated since the early stages of cardiac development. Obscurin-associated kinase was expressed at higher levels than obscurin at early stages of cardiomyogenesis. Increasing intensity of obscurin expression in the developing heart positively correlated with progressive cell differentiation and was higher in the ventricles compared to the atria. These data were supported by the results of experiments with primary cardiac cell cultures. Obscurin localization changed from a weakly immunopositive diffuse pattern in poorly differentiated cells to an intensely immunolabeled cross-striated distribution at the level of mid-A-bands and Z-disks during the assembly of the myofibrillar contractile apparatus. In dividing myocytes, unlike the interphase cells, obscurin translocated from disassembling myofibrils into a diffuse granulated pattern segregated separately from alpha-actinin-immunopositive aggregates. Obscurin-associated kinase was localized mainly to cell nuclei with increasing incorporation into the Z-disks during differentiation. Our results suggest that these two novel proteins are involved in the progression of cardiac myogenesis during the transition to advanced stages of heart development. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18041765      PMCID: PMC2833968          DOI: 10.1002/jcb.21551

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  37 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  How to build a myofibril.

Authors:  Joseph W Sanger; Songman Kang; Cornelia C Siebrands; Nancy Freeman; Aiping Du; Jushuo Wang; Andrea L Stout; Jean M Sanger
Journal:  J Muscle Res Cell Motil       Date:  2005       Impact factor: 2.698

3.  Essential role of obscurin in cardiac myofibrillogenesis and hypertrophic response: evidence from small interfering RNA-mediated gene silencing.

Authors:  Andrei B Borisov; Sarah B Sutter; Aikaterini Kontrogianni-Konstantopoulos; Robert J Bloch; Margaret V Westfall; Mark W Russell
Journal:  Histochem Cell Biol       Date:  2005-10-05       Impact factor: 4.304

4.  Primary structure of the kinase domain region of rabbit skeletal and cardiac muscle titin.

Authors:  M G Sebestyén; J D Fritz; J A Wolff; M L Greaser
Journal:  J Muscle Res Cell Motil       Date:  1996-06       Impact factor: 2.698

5.  The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes. Involvement of Rho kinase.

Authors:  M Hoshijima; V P Sah; Y Wang; K R Chien; J H Brown
Journal:  J Biol Chem       Date:  1998-03-27       Impact factor: 5.157

6.  Real time quantitative PCR.

Authors:  C A Heid; J Stevens; K J Livak; P M Williams
Journal:  Genome Res       Date:  1996-10       Impact factor: 9.043

7.  Inhibition of myosin light chain kinase by p21-activated kinase.

Authors:  L C Sanders; F Matsumura; G M Bokoch; P de Lanerolle
Journal:  Science       Date:  1999-03-26       Impact factor: 47.728

8.  Structural basis for activation of the titin kinase domain during myofibrillogenesis.

Authors:  O Mayans; P F van der Ven; M Wilm; A Mues; P Young; D O Fürst; M Wilmanns; M Gautel
Journal:  Nature       Date:  1998-10-29       Impact factor: 49.962

9.  The kinase domain of titin controls muscle gene expression and protein turnover.

Authors:  Stephan Lange; Fengqing Xiang; Andrey Yakovenko; Anna Vihola; Peter Hackman; Elena Rostkova; Jakob Kristensen; Birgit Brandmeier; Gereon Franzen; Birgitta Hedberg; Lars Gunnar Gunnarsson; Simon M Hughes; Sylvie Marchand; Thomas Sejersen; Isabelle Richard; Lars Edström; Elisabeth Ehler; Bjarne Udd; Mathias Gautel
Journal:  Science       Date:  2005-03-31       Impact factor: 47.728

10.  Developmental regulation of myosin gene expression in mouse cardiac muscle.

Authors:  G E Lyons; S Schiaffino; D Sassoon; P Barton; M Buckingham
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

View more
  19 in total

1.  The rho-guanine nucleotide exchange factor domain of obscurin activates rhoA signaling in skeletal muscle.

Authors:  Diana L Ford-Speelman; Joseph A Roche; Amber L Bowman; Robert J Bloch
Journal:  Mol Biol Cell       Date:  2009-07-15       Impact factor: 4.138

Review 2.  Muscle giants: molecular scaffolds in sarcomerogenesis.

Authors:  Aikaterini Kontrogianni-Konstantopoulos; Maegen A Ackermann; Amber L Bowman; Solomon V Yap; Robert J Bloch
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

3.  Loss of giant obscurins promotes breast epithelial cell survival through apoptotic resistance.

Authors:  Nicole A Perry; Marey Shriver; Marie G Mameza; Bryan Grabias; Eric Balzer; Aikaterini Kontrogianni-Konstantopoulos
Journal:  FASEB J       Date:  2012-03-21       Impact factor: 5.191

4.  The kinase domains of obscurin interact with intercellular adhesion proteins.

Authors:  Li-Yen R Hu; Aikaterini Kontrogianni-Konstantopoulos
Journal:  FASEB J       Date:  2013-02-07       Impact factor: 5.191

5.  Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis.

Authors:  M Shriver; K M Stroka; M I Vitolo; S Martin; D L Huso; K Konstantopoulos; A Kontrogianni-Konstantopoulos
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

Review 6.  Obscure functions: the location-function relationship of obscurins.

Authors:  Heather R Manring; Olivia A Carter; Maegen A Ackermann
Journal:  Biophys Rev       Date:  2017-03-29

7.  New aspects of obscurin in human striated muscles.

Authors:  Lena Carlsson; Ji-Guo Yu; Lars-Eric Thornell
Journal:  Histochem Cell Biol       Date:  2008-03-19       Impact factor: 4.304

8.  Obscurin determines the architecture of the longitudinal sarcoplasmic reticulum.

Authors:  Stephan Lange; Kunfu Ouyang; Gretchen Meyer; Li Cui; Hongqiang Cheng; Richard L Lieber; Ju Chen
Journal:  J Cell Sci       Date:  2009-07-07       Impact factor: 5.285

Review 9.  Obscurins: unassuming giants enter the spotlight.

Authors:  Nicole A Perry; Maegen A Ackermann; Marey Shriver; Li-Yen R Hu; Aikaterini Kontrogianni-Konstantopoulos
Journal:  IUBMB Life       Date:  2013-03-20       Impact factor: 3.885

10.  Localization of ank1.5 in the sarcoplasmic reticulum precedes that of SERCA and RyR: relationship with the organization of obscurin in developing sarcomeres.

Authors:  Emiliana Giacomello; Vincenzo Sorrentino
Journal:  Histochem Cell Biol       Date:  2008-11-11       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.